表达猪传染性胃肠炎病毒S基因的重组乳酸乳球菌的构建及免疫原性分析

根据猪传染性胃肠炎病毒纤突(S)蛋白的全基因序列及表达载体质粒的基因融合特点,设计一对引物,进行PCR扩增,获得含有TGEVS基因4个主要抗原位点的约2000bp的目的片段,将其与分泌表达的载体质粒pNZ8112进行连接,通过电击转化进入宿主菌乳酸乳球菌NZ9000细胞内,在乳链菌肽(Nisin)的诱导下进行表达,通过SDS-PAGE和Western blot分析,表明TGEVS蛋白在乳酸乳球菌中获得表达,所表达的TGEVS蛋白具有与TGE病毒一样的抗原特异性。间接免疫荧光试验表明重组菌表达蛋白定位于菌体表面。将表达TGEVS蛋白的重组乳酸乳球菌及空质粒菌株分别口服免疫BALB/c小鼠,收集粪便样品进行抗体检测,结果表明分泌型的重组菌pNZ8112-Sa/NZ9000免疫小鼠能够产生明显的抗TGEVsIgA抗体。

Construction of recombinant Lactococcus lactis expressing porcine transmissible gastroenteritis spike glycoprotein and analysis of immunogenicity

Transmissible gastroenteritis virus (TGEV), is an enteropathogenic coronavirus that causes a highly fatal acute diarrhea in newborn pigs. It's typically clinical manifestations consist of omitting, severe diarrhea, loss water and highly infectious disease. All kinds and ages of pigs can be infected. Particular, the mortality piglets under 3 weeks may reach 100%. The effective protection against TGEV requires the development of vaccines that are able to induce local mucosal immunization. Lactococcus lactis was selected as a bacterial carrier for the expression of TGEV spike glycoprotein. The gene of S glycoprotein was cloned into the Lactococcus lactis vectors pNZ8112. An approximately 2000bps fragments of TGEV gene S that encompasses all the four major antigenic domains critical for neutralization was transformed into Lactococcus lactis NZ9000 by electroporation, resulting in the recombinant strain pNZ8112-Sa/NZ9000. The recombinant glycoprotein S was detected by SDS-PAGE and Western blot after induced by 1ng/mL nisin. The result indicated that the expressed product maintain the antigenicity of TGEV as expected. In order to detect the location of expressed protein, the yellow and green fluorescence of the recombinant strain pNZ8112-Sa/NZ9000 was detected by the IFA experiments, which indicated that the expressed recombinant protein was secreted and located on the surface of the bacterium cell. Oral immunization of BALB/c mice with recombinant strain that constitutively express the 66kDa fragment of the glycoprotein S, Specific anti-TGEV glycoprotein S secret immunoglobulin A (sIgA) antibodies were detected by indirect enzyme linked immunosorbent assay (ELISA) in the feces after immunization. It was showed that the mice immunized with pNZ8112-Sa/NZ9000 recombinant strain had produced clear antibody level anti TGEV, and which had provided important substance foundation and explored the feasibility of Lactobacillus as oral vaccine.